Twin commercial reskilling at a single-cell biotech firm

Case / 2024−06 Biotech / life sciences Two cross-industry conversions

Two scientific specialists at a single-cell biotechnology firm in Singapore, reskilled into expanded commercial-and-applications roles as the company shifted from a pure R&D outpost into a regional commercial hub serving institutional clients.

Industry context

The Singapore arm of the biotech firm had operated as a research outpost: scientists at the bench, supporting global R&D priorities. The strategic shift to a regional commercial hub serving institutional clients across Southeast Asia introduced new capability requirements that the existing scientific staff needed to absorb. Application support, customer-facing technical sales, and regional training responsibilities had to be built around the existing scientific expertise, rather than replacing it.

What changed and why CCP applied

Two existing scientific staff needed structured uplift to take on application support, customer-facing technical sales, and regional training responsibilities. None of those competencies had been part of their original lab-bench roles. The redesign was substantive enough to qualify under CCP reskilling: each role retained its scientific core but gained an entirely new commercial-application layer that represented more than half of the redesigned scope.

Our strategy

We treated this as a parallel reskilling engagement. Both candidates received a shared technical-commercial backbone covering regulatory awareness, customer-facing communication frameworks, and regional market context. On top of that, each candidate had individual application-domain modules tied to their specific scientific specialty. The reskilling was positioned as an expansion of scope rather than a replacement of existing duties, which kept the redesign defensible while honouring the candidates' technical depth.

OJT activities included

Outcome

Roles covered
Two scientific specialists reskilled into hybrid commercial-and-applications leads
Approach
Parallel reskilling with shared technical-commercial backbone + individual application-domain modules
Status
Both applications approved
Strategic value
Client evolved two technical hires into hybrid commercial-application leads without external recruitment cost, supporting the regional commercial hub transition

The most useful pattern for biotech and life-sciences firms going through a similar transition is to start from the technical foundation the candidates already have, then build the commercial layer on top with structured training. Reskilling is more credible when the redesigned role keeps the scientific expertise central rather than treating it as a starting point that the candidate is moving away from.

Hiring or restructuring roles in biotech, life sciences, medtech, or another regulated technical environment? Get in touch to discuss whether your roles qualify for a CCP pathway.